報價延遲最少15分鐘:2025/10/24 08:18 EDT
盤前時段
|
||||
|
77.9 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.74/1.56
|
|
企業價值
2.44B
|
| 資產負債 |
|
每股賬面淨值
22.92
|
| 現金流量 |
|
現金流量率
0.05
|
| 損益表 |
|
收益
802.80M
|
|
每股收益
19.28
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/10/24 08:18 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States. |
